 |
Prescription and Over-the-Counter Drug Product List - 20th Edition
Cumulative Supplement Number 1: January 2000
PRESCRIPTION DRUG PRODUCT LIST 1
20TH EDITION
ADDITIONS/DELETIONS FOR RX DRUG PRODUCT LIST / CUMULATIVE SUPPLEMENT NUMBER 1 / JAN'2000
> ADD > CALCIUM CHLORIDE CEFTIBUTEN DIHYDRATE
> ADD > INJECTABLE; INJECTION POWDER FOR RECONSTITUTION; ORAL
> ADD > CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER CEDAX
> ADD > + ABBOTT 100MG/ML N21117 001 > ADD > DJ PHARMA EQ 90MG BASE/5ML N50686 001
> ADD > JAN 28, 2000 > ADD > DEC 20, 1995
> ADD > + EQ 180MG BASE/5ML N50686 002
> ADD > DEC 20, 1995
CARTEOLOL HYDROCHLORIDE > DLT > + SCHERING PLOUGH EQ 90MG BASE/5ML N50686 001
> DLT > DEC 20, 1995
SOLUTION/DROPS; OPHTHALMIC > DLT > + EQ 180MG BASE/5ML N50686 002
> ADD > CARTEOLOL HCL > DLT > DEC 20, 1995
> ADD > AT ALCON 1% N75476 001
> ADD > JAN 03, 2000
> ADD > AT BAUSCH AND LOMB 1% N75546 001 CEFTRIAXONE SODIUM
> ADD > JAN 20, 2000
OCUPRESS INJECTABLE; INJECTION
> ADD > AT + CIBA 1% N19972 001 ROCEPHIN
> ADD > MAY 23, 1990 > ADD > + HLR EQ 250MG BASE/VIAL N50585 001
> DLT > + 1% N19972 001 > ADD > DEC 21, 1984
> DLT > MAY 23, 1990 > ADD > + EQ 500MG BASE/VIAL N50585 002
> ADD > DEC 21, 1984
> ADD > + EQ 1GM BASE/VIAL N50585 003
CEFDINIR > ADD > DEC 21, 1984
> ADD > + EQ 2GM BASE/VIAL N50585 004
CAPSULE; ORAL > ADD > DEC 21, 1984
OMNICEF > ADD > + EQ 10GM BASE/VIAL N50585 005
> ADD > + ABBOTT 300MG N50739 001 > ADD > DEC 21, 1984
> ADD > DEC 04, 1997 > DLT > + ROCHE EQ 250MG BASE/VIAL N50585 001
> DLT > + PARKE DAVIS 300MG N50739 001 > DLT > DEC 21, 1984
> DLT > DEC 04, 1997 > DLT > + EQ 500MG BASE/VIAL N50585 002
> DLT > DEC 21, 1984
POWDER FOR RECONSTITUTION; ORAL > DLT > + EQ 1GM BASE/VIAL N50585 003
OMNICEF > DLT > DEC 21, 1984
> ADD > + ABBOTT 125MG/5ML N50749 001 > DLT > + EQ 2GM BASE/VIAL N50585 004
> ADD > DEC 04, 1997 > DLT > DEC 21, 1984
> DLT > + PARKE DAVIS 125MG/5ML N50749 001 > DLT > + EQ 10GM BASE/VIAL N50585 005
> DLT > DEC 04, 1997 > DLT > DEC 21, 1984
ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER
> ADD > @ HLR EQ 10MG BASE/ML N50624 001
CEFTIBUTEN DIHYDRATE > ADD > FEB 11, 1987
> ADD > + EQ 20MG BASE/ML N50624 002
CAPSULE; ORAL > ADD > FEB 11, 1987
CEDAX > ADD > + EQ 40MG BASE/ML N50624 003
> ADD > + DJ PHARMA EQ 400MG BASE N50685 002 > ADD > FEB 11, 1987
> ADD > DEC 20, 1995 > DLT > @ ROCHE EQ 10MG BASE/ML N50624 001
> DLT > + SCHERING PLOUGH EQ 400MG BASE N50685 002 > DLT > FEB 11, 1987
> DLT > DEC 20, 1995 > DLT > + EQ 20MG BASE/ML N50624 002
> DLT > FEB 11, 1987
CEFTRIAXONE SODIUM CROMOLYN SODIUM
INJECTABLE; INJECTION SOLUTION; INHALATION
ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER CROMOLYN SODIUM
> DLT > + ROCHE EQ 40MG BASE/ML N50624 003 > ADD > AN STERIPAK 10MG/ML N75271 001
> DLT > FEB 11, 1987 > ADD > JAN 18, 2000
CEFTRIAXONE SODIUM; LIDOCAINE CYCLOPENTOLATE HYDROCHLORIDE
INJECTABLE; INJECTION SOLUTION/DROPS; OPHTHALMIC
ROCEPHIN KIT CYCLOPENTOLATE HCL
> ADD > + HLR EQ 1GM BASE/VIAL,N/A;N/A, > ADD > AT ALCON UNIVERSAL 1% N89162 001
> ADD > 1% N50585 006 > ADD > JAN 24, 1991
> ADD > MAY 08, 1996 > DLT > AT STERIS 1% N89162 001
> ADD > + EQ 500MG BASE/VIAL,N/A;N/A, > DLT > JAN 24, 1991
> ADD > 1% N50585 007
> ADD > MAY 08, 1996
> DLT > + ROCHE EQ 1GM BASE/VIAL,N/A;N/A, CYCLOSPORINE
> DLT > 1% N50585 006
> DLT > MAY 08, 1996 CAPSULE; ORAL
> DLT > + EQ 500MG BASE/VIAL,N/A;N/A, CYCLOSPORINE
> DLT > 1% N50585 007 > ADD > AB EON 25MG N65017 002
> DLT > MAY 08, 1996 > ADD > JAN 13, 2000
> ADD > AB 100MG N65017 001
> ADD > JAN 13, 2000
> ADD > CEVIMELINE HYDROCHLORIDE NEORAL
> ADD > AB NOVARTIS 25MG N50715 001
> ADD > CAPSULE; ORAL > ADD > JUL 14, 1995
> ADD > EVOXAC > ADD > AB + 100MG N50715 002
> ADD > + SNOWBRAND EQ 30MG BASE N20989 002 > ADD > JUL 14, 1995
> ADD > JAN 11, 2000 > DLT > BX 25MG N50715 001
> DLT > JUL 14, 1995
> DLT > BX + 100MG N50715 002
CLINDAMYCIN PHOSPHATE > DLT > JUL 14, 1995
GEL; TOPICAL
CLEOCIN T DAUNORUBICIN HYDROCHLORIDE
> ADD > AB + PHARMACIA AND UPJOHN EQ 1% BASE N50615 001
> ADD > JAN 07, 1987 INJECTABLE; INJECTION
> DLT > + EQ 1% BASE N50615 001 DAUNORUBICIN HCL
> DLT > JAN 07, 1987 > ADD > AP + BEDFORD EQ 5MG BASE/ML N50731 001
> ADD > CLINDAMYCIN PHOSPHATE > ADD > JAN 30, 1998
> ADD > AB ALTANA EQ 1% BASE N64160 001 > DLT > + EQ 5MG BASE/ML N50731 001
> ADD > JAN 28, 2000 > DLT > JAN 30, 1998
> ADD > AP GENSIA SICOR PHARMS EQ 5MG BASE/ML N65035 001
> ADD > JAN 24, 2000
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE ETHANOLAMINE OLEATE
SUSPENSION/DROPS; OPHTHALMIC INJECTABLE; INJECTION
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE ETHAMOLIN
> ADD > AT ALCON UNIVERSAL 0.1%;EQ 3.5MG BASE/ML; > DLT > + CYPROS 50MG/ML N19357 001
> ADD > 10,000 UNITS/ML N62721 001 > DLT > DEC 22, 1988
> ADD > NOV 17, 1986 > ADD > + QUESTCOR PHARM 50MG/ML N19357 001
> DLT > AT STERIS 0.1%;EQ 3.5MG BASE/ML; > ADD > DEC 22, 1988
> DLT > 10,000 UNITS/ML N62721 001
> DLT > NOV 17, 1986
FLUOROURACIL
DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE; INJECTION
FLUOROURACIL
SOLUTION/DROPS; OPHTHALMIC, OTIC > ADD > AP GENSIA SICOR PHARMS 50MG/ML N40333 001
DEXAMETHASONE SODIUM PHOSPHATE > ADD > JAN 27, 2000
> ADD > AT ALCON UNIVERSAL EQ 0.1% PHOSPHATE N88771 001
> ADD > JAN 16, 1985
GENTAMICIN SULFATE
SOLUTION/DROPS; OPHTHALMIC, OTIC
DEXAMETHASONE SODIUM PHOSPHATE SOLUTION/DROPS; OPHTHALMIC
> DLT > AT STERIS EQ 0.1% PHOSPHATE N88771 001 GENTAMICIN SULFATE
> DLT > JAN 16, 1985 > ADD > AT ALCON UNIVERSAL EQ 0.3% BASE N62523 001
> ADD > NOV 25, 1985
> DLT > AT STERIS EQ 0.3% BASE N62523 001
DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE > DLT > NOV 25, 1985
SOLUTION/DROPS; OPHTHALMIC
NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE HEPARIN SODIUM
> ADD > AT ALCON UNIVERSAL EQ 0.1% PHOSPHATE;
> ADD > EQ 3.5MG BASE/ML N62714 001 INJECTABLE; INJECTION
> ADD > JUL 21, 1986 HEPARIN LOCK FLUSH
> DLT > AT STERIS EQ 0.1% PHOSPHATE; > DLT > @ STERIS 100 UNITS/ML N17064 001
> DLT > EQ 3.5MG BASE/ML N62714 001 > ADD > @ 100 UNITS/ML N17064 001
> DLT > JUL 21, 1986 HEPARIN SODIUM
> DLT > AP STERIS 5,000 UNITS/ML N17064 003
> DLT > AP 10,000 UNITS/ML N17064 004
DILTIAZEM HYDROCHLORIDE > DLT > AP 20,000 UNITS/ML N17064 005
> DLT > AP 40,000 UNITS/ML N17064 006
CAPSULE, EXTENDED RELEASE; ORAL > ADD > @ 5,000 UNITS/ML N17064 003
DILTIAZEM HCL > ADD > @ 10,000 UNITS/ML N17064 004
> ADD > AB3 BIOVAIL 120MG N20939 001 > ADD > @ 20,000 UNITS/ML N17064 005
> ADD > JAN 28, 2000 > ADD > @ 40,000 UNITS/ML N17064 006
> ADD > AB3 180MG N20939 002
> ADD > JAN 28, 2000
> ADD > AB3 240MG N20939 003
> ADD > JAN 28, 2000
> ADD > AB3 300MG N20939 004
> ADD > JAN 28, 2000
HYDROCHLOROTHIAZIDE METAPROTERENOL SULFATE
CAPSULE; ORAL SYRUP; ORAL
> ADD > HYDROCHLOROTHIAZIDE METAPROTERENOL SULFATE
> ADD > AB MYLAN 12.5MG N75640 001 > ADD > AA NOVEX 10MG/5ML N75235 001
> ADD > JAN 28, 2000 > ADD > JAN 27, 2000
MICROZIDE
> ADD > AB + WATSON LABS 12.5MG N20504 001
> ADD > DEC 27, 1996 MORPHINE SULFATE
> DLT > + 12.5MG N20504 001
> DLT > DEC 27, 1996 TABLET, EXTENDED RELEASE; ORAL
MORPHINE SULFATE
> ADD > AB ESI LEDERLE 15MG N75407 001
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE > ADD > JAN 28, 2000
SUSPENSION/DROPS; OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OCTREOTIDE ACETATE
> ADD > AT ALCON UNIVERSAL 1%;EQ 3.5MG BASE/ML;
> ADD > 10,000 UNITS/ML N62874 001 INJECTABLE; INJECTION
> ADD > MAY 11, 1988 SANDOSTATIN
> DLT > AT STERIS 1%;EQ 3.5MG BASE/ML; > DLT > NOVARTIS EQ 0.2MG BASE/ML N19667 004
> DLT > 10,000 UNITS/ML N62874 001 > DLT > JUN 12, 1991
> DLT > MAY 11, 1988 > DLT > EQ 1MG BASE/ML N19667 005
> DLT > JUN 12, 1991
SUSPENSION/DROPS; OTIC > ADD > + EQ 0.2MG BASE/ML N19667 004
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE > ADD > JUN 12, 1991
> ADD > AT ALCON UNIVERSAL 1%;EQ 3.5MG BASE/ML; > ADD > + EQ 1MG BASE/ML N19667 005
> ADD > 10,000 UNITS/ML N62488 001 > ADD > JUN 12, 1991
> ADD > NOV 06, 1985 SANDOSTATIN LAR
> DLT > AT STERIS 1%;EQ 3.5MG BASE/ML; > DLT > NOVARTIS EQ 10MG BASE/VIAL N21008 001
> DLT > 10,000 UNITS/ML N62488 001 > DLT > NOV 25, 1998
> DLT > NOV 06, 1985 > DLT > EQ 20MG BASE/VIAL N21008 002
> DLT > NOV 25, 1998
> ADD > + EQ 10MG BASE/VIAL N21008 001
INULIN > ADD > NOV 25, 1998
> ADD > + EQ 20MG BASE/VIAL N21008 002
INJECTABLE; INJECTION > ADD > NOV 25, 1998
INULIN AND SODIUM CHLORIDE
> DLT > + CYPROS 100MG/ML N02282 001
> ADD > + QUESTCOR PHARM 100MG/ML N02282 001 > ADD > OXCARBAZEPINE
> ADD > TABLET; ORAL
IOTHALAMATE SODIUM, I-125 > ADD > TRILEPTAL
> ADD > NOVARTIS 150MG N21014 001
INJECTABLE; INJECTION > ADD > JAN 14, 2000
GLOFIL-125 > ADD > 300MG N21014 002
> DLT > CYPROS 250-300 uCi/ML N17279 001 > ADD > JAN 14, 2000
> ADD > QUESTCOR PHARM 250-300 uCi/ML N17279 001 > ADD > + 600MG N21014 003
> ADD > JAN 14, 2000
OXYCODONE HYDROCHLORIDE SULFACETAMIDE SODIUM
TABLET, EXTENDED RELEASE; ORAL SOLUTION/DROPS; OPHTHALMIC
> DLT > ROXICODONE SULFACETAMIDE SODIUM
> DLT > BX ROXANE 10MG N20932 001 > ADD > AT ALCON UNIVERSAL 10% N89560 001
> DLT > OCT 26, 1998 > ADD > OCT 18, 1988
> DLT > + 30MG N20932 002 > DLT > AT STERIS 10% N89560 001
> DLT > OCT 26, 1998 > DLT > OCT 18, 1988
> ADD > @ 10MG N20932 001
> ADD > OCT 26, 1998
> ADD > @ 30MG N20932 002 TRIMETHOPRIM HYDROCHLORIDE
> ADD > OCT 26, 1998
SOLUTION; ORAL
PRIMSOL
PREDNISOLONE > DLT > ASCENT PEDS EQ 25MG BASE/5ML N74374 001
> DLT > JUN 23, 1995
SYRUP; ORAL > ADD > + EQ 25MG BASE/5ML N74374 001
PREDNISOLONE > ADD > JUN 23, 1995
> ADD > AA COPLEY PHARM 15MG/5ML N40322 001 > ADD > + EQ 50MG BASE/5ML N74973 001
> ADD > JAN 19, 2000 > ADD > JAN 24, 2000
PREDNISOLONE SODIUM PHOSPHATE TROPICAMIDE
SOLUTION/DROPS; OPHTHALMIC SOLUTION/DROPS; OPHTHALMIC
PREDNISOLONE SODIUM PHOSPHATE TROPICAMIDE
> ADD > AT ALCON UNIVERSAL EQ 0.11% PHOSPHATE N81043 001 > ADD > AT ALCON UNIVERSAL 1% N89172 001
> ADD > OCT 24, 1991 > ADD > DEC 28, 1990
> ADD > AT EQ 0.9% PHOSPHATE N81044 001 > DLT > AT STERIS 1% N89172 001
> ADD > OCT 24, 1991 > DLT > DEC 28, 1990
> DLT > AT STERIS EQ 0.11% PHOSPHATE N81043 001
> DLT > OCT 24, 1991
> DLT > AT EQ 0.9% PHOSPHATE N81044 001
> DLT > OCT 24, 1991
PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM
SOLUTION/DROPS; OPHTHALMIC
SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE
> ADD > AT ALCON UNIVERSAL EQ 0.23% PHOSPHATE;10% N73630 001
> ADD > MAY 27, 1993
> DLT > AT STERIS EQ 0.23% PHOSPHATE;10% N73630 001
> DLT > MAY 27, 1993
IBUPROFEN
CAPSULE; ORAL
IBUPROFEN
> DLT > PHARM FORM 200MG N74782 001
> DLT > JUL 06, 1998
> ADD > + 200MG N74782 001
> ADD > JUL 06, 1998
LOPERAMIDE HYDROCHLORIDE
TABLET; ORAL
LOPERAMIDE HCL
> ADD > PERRIGO 2MG N75232 001
> ADD > JAN 06, 2000
RANITIDINE HYDROCHLORIDE
TABLET; ORAL
RANITIDINE
> ADD > CHELSEA LABS EQ 75MG BASE N75212 001
> ADD > JAN 14, 2000
> ADD > GENPHARM EQ 75MG BASE N75497 001
> ADD > JAN 14, 2000
> ADD > RANBAXY EQ 75MG BASE N75132 001
> ADD > JAN 14, 2000
> ADD > EQ 75MG BASE N75254 001
> ADD > JAN 14, 2000
> ADD > ZENITH GOLDLINE EQ 75MG BASE N75296 001
> ADD > JAN 14, 2000
Last update: July 15, 2005 |
|
